Location: Home
  • search
  • go
  • Relate News
  • 9/24/2023Chime Biologics Enter Global Strategic Deal with Panolos for Multi-spe...
  • 9/24/2023PackGene and Kudo Partner to Offer Customized mRNA Manufacturing Servi...
  • 9/24/2023Strategies for Asian Business Navigating a New Era (McKinsey)
  • 9/24/2023Improving Access to Medicines and Beyond: the National Volume-based Pr...
  • 9/21/2023Meitheal Licenses U.S. Rights of Insulin Biosimilars from Tonghua Dong...
  • 9/21/2023Recent Executive Moves
  • 9/20/2023NHSA Clears Two Additional Drugs from Form Evaluation for 2023 NRDL In...
  • 9/20/2023Everest Medicines Enters into Collaboration and License Agreement with...
  • 9/20/2023IQVIA: Chinese Hospital Drug Market Rebounded in MAT Q2/2023
  • 9/20/2023A Share-Listed Chinese MedPharm Cos Report Broadly Positive Performanc...
  • 9/20/2023Chinese Drugmakers Hit a Fundraising and Licensing Slump in August (Ph...
  • 9/19/2023Novartis, BeiGene Agree to Terminate Deal for Cancer Drug Candidate
  • 9/18/2023GenScript Expands Range of Reagent Services, Adding Circular RNA and L...
  • 9/17/2023In China's Changing Economy, MNCs Must Rethink the Mantra of Going Big...
  • 9/15/2023U.S. and Other Foreign Venture Firms Pull Back From China's Biotech Se...
  • 9/15/2023Cure Genetics, Frametact to Develop Brain Disease Gene Therapies in $6...
  • 9/14/2023China to Manage Monkeypox as Category B Infectious Disease as Covid-19
  • 9/14/2023U.S.-China Track II Dialogue on Healthcare - July 2023 Consensus
  • 9/13/2023Are China's Healthcare and Biopharma Sectors Really Open for Investmen...
  • 9/13/2023AriBio, Shanghai Pharma to Commercialize Oral Alzheimer's Drug AR1001
  • 9/13/2023Clover Biopharma Launches Quadrivalent Influenza Vaccine in Mainland C...
  • 9/13/2023NHSA Issues the Notice on Further Advancing the Intelligent Review and...
  • 9/8/2023Recent Official and Executive Moves
  • 9/7/2023MSD Plans to Boost New Product Launch and Pharma R&D in China
  • 9/6/2023NMPA Solicits Comments on the Guidelines for the Inspection of Third-P...
  • 9/1/2023NHSA Issues the List of Drugs Passing Preliminary Form Evaluation for ...
  • 9/1/2023Recent Executive Moves
  • 8/31/2023IQVIA: Chinese Retail Pharmacy Sales up 8.9% in MAT Q2/2023
  • 8/31/2023NMPA and Chinese Customs Announce Addition of Taizhou as a Drug Import...
  • 8/31/2023NHSA to Cancel Hospital Payment Rights for Drug and Consumable Procure...
  • Page:40/355 Total number of articles:10627: [First][<<] [38] [39] [40] [41] [42] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group